(Q35643944)

9 August 2017

1 reference

title

Smallpox vaccine: problems and prospects (English)

1 reference

9 August 2017

1 reference

1

Gregory A Poland

1 reference

9 August 2017

John M Neff

2

1 reference

9 August 2017

publication date

1 November 2003

1 reference

Immunology and Allergy Clinics of North America

9 August 2017

published in

1 reference

9 August 2017

volume

23

1 reference

9 August 2017

issue

4

1 reference

9 August 2017

page(s)

731-743

1 reference

The looming threat of bioterrorism

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900096-1

7 January 2021

Smallpox vaccination in 2003: key information for clinicians

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900096-1

7 January 2021

The case for voluntary smallpox vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900096-1

7 January 2021

A model for a smallpox-vaccination policy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900096-1

7 January 2021

Diagnosis and management of smallpox

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900096-1

7 January 2021

Smallpox: clinical and epidemiologic features

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900096-1

7 January 2021

Smallpox as a Biological Weapon

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900096-1

7 January 2021

Clinical responses to undiluted and diluted smallpox vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900096-1

7 January 2021

Stability of Undiluted and Diluted Vaccinia‐Virus Vaccine, Dryvax

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900096-1

7 January 2021

The complete DNA sequence of vaccinia virus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900096-1

7 January 2021

Immunologic responses to vaccinia vaccines administered by different parenteral routes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900096-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900096-1

7 January 2021

Immune response in humans after vaccination with vaccinia virus: generation of a virus-specific cytotoxic activity by human peripheral lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900096-1

7 January 2021

Primary induction of human CD8+ cytotoxic T lymphocytes and interferon-gamma-producing T cells after smallpox vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900096-1

7 January 2021

Quantitation of CD8+ T cell responses to newly identified HLA-A*0201-restricted T cell epitopes conserved among vaccinia and variola (smallpox) viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900096-1

7 January 2021

Identification of vaccinia virus epitope-specific HLA-A*0201-restricted T cells and comparative analysis of smallpox vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900096-1

7 January 2021

Can postexposure vaccination against smallpox succeed?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900096-1

7 January 2021

Studies in smallpox and vaccination. 1913.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900096-1

7 January 2021

The persistence of neutralizing antibodies after revaccination against smallpox

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900096-1

7 January 2021

Smallpox in Europe, 1950-1971

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900096-1

7 January 2021

Complications of smallpox vaccination, 1968.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900096-1

7 January 2021

Complications of smallpox vaccination. I. National survey in the United States, 1963.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900096-1

7 January 2021

US military smallpox vaccination program experience

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900096-1

7 January 2021

Contact vaccinia--transmission of vaccinia from smallpox vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900096-1

7 January 2021

Smallpox vaccination: Risk considerations for patients with atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900096-1

7 January 2021

How contagious is vaccinia?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900096-1

7 January 2021

Myopericarditis following smallpox vaccination among vaccinia-naive US military personnel

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900096-1

7 January 2021

Smallpox vaccination and patients with human immunodeficiency virus infection or acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900096-1

7 January 2021

The role of mass spectrometry in vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900096-1

7 January 2021

Partial deletion of the human host range gene in the attenuated vaccinia virus MVA.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900096-1

7 January 2021

Modified vaccinia virus Ankara undergoes limited replication in human cells and lacks several immunomodulatory proteins: implications for use as a human vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8561%2803%2900096-1

7 January 2021

10.1016/S0889-8561(03)00096-1

Identifiers

DOI

1 reference

release_esqbm6mymrb4xg73hoxqacgrem

9 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/esqbm6mymrb4xg73hoxqacgrem

24 November 2022

mapped directly with Wikidata item

1 reference